The iShares Evolved U.S. Innovative Healthcare ETF (IEIH) primarily allocates its capital to the equity securities of U.S.-based pharmaceutical and biotechnology companies. Under typical market conditions, a minimum of 80% of the fund's net assets will be invested in the common stocks of firms across various market capitalizations, including large, mid, and small-cap companies. The ETF also targets enterprises categorized within the "Innovative Healthcare Evolved Sector" — specifically, those whose financial profiles have historically aligned with conventional pharmaceutical and biotechnology businesses. It is important to note that this fund operates as a non-diversified investment vehicle.